68Ga PSMA PET/CT in Patients with Prostate Cancer
No contributors found.
Release Date: 2024-06-10
Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) is a new method of imaging prostate cancer that increases diagnostic accuracy in detecting reccurrent disease or metastasis and guiding therapy. Gallium-68 PSMA ligand PET/CT has increased sensitivity of detection of local recurrence or metastases at low PSA levels. PSMA PET/CT has also inceased sensitivity and [...]
